How can IROs raise investor spirits during market mayhem?
The year 2000 was a very good one for Forest Laboratories. Amid a backdrop of plummeting indices, shares in the New York-based drug company were up over 100 percent, ending the year in the high $60s. And then the general malaise afflicting the great majority of stocks caught up with Forest. 'We were hit hard in the first weeks of the new year. We quickly dropped from the high $60s to the mid $50s,' says Charles Triano, Forest's vice president of investor relations.Of course, for some companies,
You need to register to access 3 free deep dive articles per month. To continue reading please register or login below..
- Unlimited deep dives
- Data-driven research around key topics
- Buy-side insights
- Benchmarking reports
From
$1495
